Safety and Efficacy of Lastacaft for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea

Trial Profile

Safety and Efficacy of Lastacaft for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Nov 2016

At a glance

  • Drugs Alcaftadine (Primary)
  • Indications Allergic conjunctivitis
  • Focus Adverse reactions
  • Sponsors Allergan
  • Most Recent Events

    • 09 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 25 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top